Inhibrx Biosciences, Inc. Quarterly Liabilities and Equity in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Inhibrx Biosciences, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2023 to Q3 2024.
  • Inhibrx Biosciences, Inc. Liabilities and Equity for the quarter ending September 30, 2024 was $223M.
Liabilities and Equity, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $223M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $258M Jun 30, 2024 10-Q 2024-08-13
Q4 2023 $308M Dec 31, 2023 10-Q 2024-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.